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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYTo understand how haploinsufficiency of progranulin (PGRN) causes frontotemporal dementia (FTD), we created induced pluripotent
stem cells (iPSCs) from patients carrying the GRNIVS1+5G > C mutation (FTD-iPSCs). FTD-iPSCs were fated to cortical neurons, the cells
most affected in FTD. Although generation of neuroprogenitors was unaffected, their further differentiation into CTIP2-, FOXP2-, or
TBR1-TUJ1 double-positive cortical neurons, but not motorneurons, was significantly decreased in FTD-neural progeny. Zinc finger
nuclease-mediated introduction of GRN cDNA into the AAVS1 locus corrected defects in cortical neurogenesis, demonstrating that
PGRN haploinsufficiency causes inefficient cortical neuron generation. RNA sequencing analysis confirmed reversal of the altered gene
expression profile following genetic correction. We identified the Wnt signaling pathway as one of the top defective pathways in FTD-
iPSC-derived neurons, which was reversed following genetic correction. Differentiation of FTD-iPSCs in the presence of aWNT inhibitor
mitigated defective corticogenesis. Therefore, we demonstrate that PGRN haploinsufficiency hampers corticogenesis in vitro.INTRODUCTION
Frontotemporal dementia (FTD) accounts for 50% of de-
mentia cases before the age of 60. Up to 40% of FTD pa-
tients have a familial history (Goldman et al., 2005; van
Swieten andHeutink, 2008) due tomutations in themicro-
tubule-associated protein tau gene (MAPT), progranulin
gene (GRN), or C9orf72 gene (Baker et al., 2006; Cruts
et al., 2006; DeJesus-Hernandez et al., 2011; Hutton et al.,
1998; Renton et al., 2011). The majority of FTD-causing
mutations in GRN are predicted to result in functional
null alleles, causing haploinsufficiency. Progranulin
(PGRN) has neurotrophic function in vitro and in vivo.
Although PGRN/ mice are viable, they do not recapitu-
late all the features of FTD (Kayasuga et al., 2007).
Human somatic cell reprogramming to a pluripotent
state (induced pluripotent stem cells; iPSCs)(Takahashi
et al., 2007a) can create human disease models in vitro us-
ing patient-derived iPSCs (Kim, 2014), including neurode-16 Stem Cell Reports j Vol. 4 j 16–24 j January 13, 2015 j ª2015 The Authorgenerative diseases (Qiang et al., 2013) and, specifically,
FTD (Almeida et al., 2012). Unlike in the published FTD-
iPSC model that differentiated iPSCs to a mixture of
neuronal cells, we evaluated cortical neuron development
from FTD-patient-derived iPSCs, as FTD is characterized
by selective neurodegeneration of the frontal and/or tem-
poral cortex (Neary et al., 2005). We demonstrate that
FTD-iPSCs carrying a GRNIVS1+5G > C mutation differ in
their ability to generate cortical neurons from control lines
(iPSCs and human embryonic stem cells; hESCs) and that
genetic correction restores this differentiation defect.RESULTS
FTD-iPSCs Differentiation into Neuroprogenitors Is
Normal
To study the effect of PGRN haploinsufficiency in human
neurogenesis, iPSC lines were generated from threes
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(Figure S1A available online) as previously described (Taka-
hashi et al., 2007b). The human embryonic stem cell line,
H9 (H9-ESC), and iPSCs from normal donor fibroblasts
(CTRL-iPSCs) were used as control lines (Figures S1B–
S1E). Transcript and protein levels of PGRN in FTD-iPSC
lines were reduced, approximately 30% and 50%, respec-
tively, compared to H9-hESCs and CTRL-iPSCs (Figures
S1F and S1G). We next induced cortical differentiation
(Espuny-Camacho et al., 2013), which induced an increase
in transcripts for the neuroprogenitor genes SOX1, PAX6,
and FABP7 (BLBP), with concomitant decrease in OCT4
expression in day (d)24 FTD-iPSCs as well as CTRL-iPSC
and H9-hESC progeny (Figure S2A). Immunostaining
confirmed that d24 neuroprogenitors did not express
OCT4.Nearly 100%of the progeny of all lines were positive
for the neuroectoderm-specific NESTIN marker, with a
PAX6-positive dorsal fate, and stained positive for BLBP
and OTX1-2 (Figure S2B). Thus, neuroprogenitor forma-
tion from FTD-iPSCs appeared normal.
Inefficient Cortical Neuron Formation fromFTD-iPSCs
We next allowed the neuroprogenitors to mature into
cortical neurons. GRN mRNA levels in FTD cells during
differentiation were approximately 50% compared to
control lines (Figure 1A). D40 progeny from CTRL- and
FTD-iPSCs contained functional neurons based on whole-
cell current-clamp analysis. FTD-iPSC neurons consistently
fired action potentials in response to depolarizing current
injections, similar to neurons from control cell lines (Fig-
ures S2CI–S2CII). Whole-cell voltage-clamp recordings
revealed time- and voltage-dependent currents during
depolarizing voltage steps, consistent with functional
voltage-gated Na+ and K+ channels (Figure S2CIII). The
cortical neurotransmitter GABA induced transmembrane
currents in FTD-iPSC-derived neurons, exhibiting the
typical features of ionotropic GABAA receptors (Fig-
ure S2CIV).We also observed spontaneous action potential
firing in FTD-iPSC neurons (Figure S2CV). Thus, FTD-iPSC
neuroprogenitors were able to differentiate into functional,
excitable neurons.
Between d24 and d40 of differentiation, transcript levels
of REELIN, CTIP2, FOXG1, FOXP2, and TBR1 progressively
increased in neural progeny from FTD- and CTRL-iPSC
lines. However, on d40, CTIP2 and FOXG1 mRNA levels
were significantly lower in FTD-iPSC than in CTRL-iPSC
progeny (Figures 1B and S2D). Also, mature TUJ1-positive
neurons coexpressed the cortical markers TBR1, FOXP2,
and CTIP2. However, compared to CTRL-iPSC and H9-
hESC progeny, only a small fraction of FTD-iPSC progeny
was positive for TUJ1 (CTRL-iPSCs, 20.7% ± 3.1%;
FTD-iPSCs, 4.0% ± 0.69%) (Figures 1C and 1D). In both
CTRL-iPSC and FTD-iPSC progeny, a proportion of undif-Stemferentiated NESTIN-positive neuroprogenitors persisted
till d40 (Figure 1E). Thus, using a cortical neuron differen-
tiation protocol, we demonstrate significantly decreased
corticogenesis from FTD-iPSCs.
To test if the neurogenesis defect was specific for cortical
neuron generation, FTD-iPSCs and hESCs were differenti-
ated to motor neurons (Hu and Zhang, 2009). Immuno-
staining for the mature motor neuron markers HB9 and
ISLET1 (Figure 1F) demonstrated that FTD3-iPSCs gener-
ated motor neurons in vitro. Thus, in contrast to what we
observed during cortical neuron differentiation, motor
neuron generation from FTD-iPSCs was not affected.
We stained cortical neuron progeny for activated cas-
pase-3 but found no significant differences in the number
of apoptotic cells between FTD andCTRL lines (Figure S2E).
AsGRNmutations in humans lead to accumulation of TDP-
43-positive inclusions, we performed TDP-43 staining,
which did not identify TDP-43 aggregates, and TDP-43 dis-
played a nuclear staining in all cells (Figure S2F).
Genetic Correction of FTD-iPSCs Restores PGRN Levels
To study the relationship between PGRN haploinsuffi-
ciency and the phenotype observed, we introduced GRN
cDNA by homologous recombination with zinc finger
nucleases (ZFNs) in the AAVS1 locus of FTD3#6-iPSCs
(Figure 2A). To identify correct targeting and absence of
random integrations, we performed genotyping based on
PCR and Southern blot analysis (Figures 2B and 2C). One
correctly homozygously targeted clone (#9) derived from
the FTD3#6 line (hereinafter referred to as FTD3#6-PGRN)
was chosen for complete characterization. As an additional
control, we recombined the GRN cDNA into the AAVS1
locus of H9-hESCs (H9-hESC-PGRN) (Figure S3A).
GRN transcript levels in FTD3#6-PGRN and H9-hESC-
PGRN cells were not significantly different from that in
H9-hESCs (Figure 2D). FTD3#6-PGRN cells expressed the
pluripotency markers at levels comparable to that of H9-
hESCs (Figures 2E and 2F) and formed teratomas (Fig-
ure 2G). Genome integrity of FTD3#6-PGRN, assessed by
array comparative genomic hybridization, revealed no sig-
nificant acquired genetic abnormalities after gene editing,
compared to the original line.
Genetic Correction of FTD-iPSCs Restores Cortical
Neuron Formation
We differentiated FTD3#6-iPSC, FTD3#6-PGRN, H9-hESC,
and H9-hESC-PGRN lines to cortical neurons. Patch clamp
recording confirmed the functional maturity of FTD3#6-
PGRN and H9-hESC-PGRN neurons (data not shown). Dif-
ferentiation toward neuroprogenitors until d24 was similar
for the FTD3#6, FTD3#6-PGRN, H9-ESC, and H9-PGRN
lines, as shown by immunostaining for neuroprogenitor
markers (Figure S3B) and quantitative RT-PCR (Figure S3C).Cell Reports j Vol. 4 j 16–24 j January 13, 2015 j ª2015 The Authors 17
Figure 1. Generation of Cortical Neurons from FTD-iPSCs and CTRL Lines
(A) GRN levels in FTD-iPSC lines compared to those in control CTRL-iPSC lines (n = 3 independent experiments). Error bars indicate mean ±
SEM. *p < 0.05, t test.
(B) CTIP and FOXG1 expression in d40 progeny of FTD-iPSC and CTRL lines (n = 3 independent experiments). Error bars indicate mean ± SEM.
*p < 0.05, t test.
(C) Immunostaining for TUJ1 and the cortical markers TBR1, CTIP2, and FOXP2. FTD1#1-iPSC and CTRL-iPSC progeny at d40 are shown. Scale
bar, 100 mm.
(D) Enumeration of TUJ1-positive cells in FTD-iPSC and CTRL-iPSC d40 progeny. FTD1#1 and FTD3#6 (FTD) lines and CTRL-iPSC and H9-hESC
(CTRL) lines are shown (n = 3 independent experiments per line. Error bars indicate mean ± SEM. *p < 0.05, t test.
(E) Immunostaining on d40 progeny for Nestin (n = 3). Scale bar, 100 mm.
(F) Immunostaining of FTD3#6 on d40 of differentiation to motorneurons for TUJ1, SMI32, HB9, and ISLET1 (n = 2). Scale bar, 100 mm.
See also Figures S1 and S2.
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progeny expressed significantly higher BLBP, FOXG1, and
CTIP2 transcript levels, which were similar to those in
H9-hESC and H9-hESC-PGRN progeny (Figure 3A; Fig-
ure S3C). Immunostaining for TUJ1 and the cortical
neuron markers CTIP2, FOXP2, and TBR1 demonstrated
that more double-positive cells were present in progeny18 Stem Cell Reports j Vol. 4 j 16–24 j January 13, 2015 j ª2015 The Authorfrom the FTD3#6-PGRN line compared to the original
isogenic line FTD3#6 (Figure 3B). Quantification of the
number of TUJ1+ and CTIP2+ neurons demonstrated that
FTD3#6-PGRN iPSC progeny contained significantly
more TUJ1+ and CTIP2+ neurons compared with FTD3#6
and that genetic correction partially rescued the fre-
quency of neurons generated compared to CTRL-iPSCss
Figure 2. Gene Targeting Using ZFNs
(A) Schematic representation of GRN gene targeting in the AAVS1 locus. HA, homology arm; CAGGS, chicken b-actin promoter; HYGR,
hygromycin resistance-thymidine kinase fusion gene. Blue arrows, primers designed for junction assay (JA) PCR at the 50 of the construct;
red arrows, PCR for JA at the 30. PUROR, puromycin resistance.
(B) JA-PCR for several clones; the clone number 9 was selected. +, positive control for 30 JA (engineered H9-hESC line created by L.O.
[unpublished data]); , negative control (FTD-iPSC not targeted).
(C) Southern blot of FTD3#6 and FTD3#6-PGRN lines.
(D) GRN expression in FTD3#6, H9-hESC, FTD3#6-PGRN, and H9-PGRN lines (NS, not significant, p = 1.6, t test; n = 3 different passages).
Error bars indicate mean ± SEM. #p = 0.07; *p < 0.05, t test.
(E) NANOG, OCT4, and DPPA4 expression in FTD3#6, FTD3#6-PGRN, and H9-hESC lines (NS, not significant, p = 0.26, t test; n = 3 different
passages). Error bars indicate mean ± SEM.
(F) Immunostaining of FTD3#6-PGRN for OCT4, SSEA4, and TRA1-60 (n = 3). Scale bar, 100 mm.
(G) FTD3#6-PGRN-derived teratoma with presence of derivatives of all three germ layers. Scale bar, 500 mm.
See also Figure S3.
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1.4%, and FTD3#6, 3.2 %± 0.3%; CTIP2: CTRL-iPSC,
14.2% ± 2.2%, FTD3#6-PGRN 6.2, ± 1.9%, and FTD3#6,
1.6% ± 0.5%) (Figure 3C). Hence, incorporation of GRN
cDNA in the AAVS1 locus restored the ability of FTD-iPSCs
to differentiate to functional neurons with a cortical fate.
As the presence of an extra copy of GRN in H9-hESCs did
not affect the differentiation potential of H9-hESCs, our
studies indicate that deficiency of PGRN is the cause of
the in vitro impaired cortical neuron generation fromStemFTD-iPSCs. Incorporation ofGRN cDNA in the AAVS1 locus
of FTD3#6 iPSCs did not affect motor neuron differentia-
tion (Figures 3D and 3E).
Genome-wide Transcriptome Analysis of d40
Neuronal Progeny Identifies Increased Wnt Signaling
To gain insights in possible mechanisms underlying the
inefficient cortical neuron generation from FTD-iPSCs, we
performed RNA sequencing (RNA-seq) of d40 progeny
from FTD3#6, FTD3#6-PGRN, and H9-hESC lines. WeCell Reports j Vol. 4 j 16–24 j January 13, 2015 j ª2015 The Authors 19
Figure 3. Rescue of Corticogenesis in FTD3#6-PGRN Cells
(A) BLBP, FOXG1, and CTIP2 expression in FTD3#6-PGRN, FTD3#6-iPSC, H9-hESC, and H9-PGRN lines (n = 3 independent experiments).
NS, not significant; p = 0.28, p = 0.23, p = 0.2 for top, middle, and bottom panels, respectively, t test. Error bars indicate mean ± SEM.
*p < 0.05, t test.
(B) Immunostaining of FTD3#6 and FTD3#6-PGRN for TUJ1 and CTIP2, FOXP2, and TBR1 (n = 3). Scale bars, 100 mm.
(C) Enumeration of TUJ1-positive (I) and CTIP2-positive cells (II) in d40 progeny from FTD3#6-PGRN iPSCs compared to FTD3#6 and CTRL-
iPSC lines (n = 3 independent experiments per line). Error bars indicate mean ± SEM. *p < 0.05, t test.
(D) Immunostaining of FTD3#6-PGRN for TUJ1 and HB9 (n = 2). Scale bar, 100 mm.
(E) Transcript levels of motorneuron precursor and mature markers (n = 2 independent experiments). Error bars indicate mean ± SEM.
See also Figure S3.
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progeny of FTD3#6 andH9-hESCs, whereas only 122 genes
were differentially expressed between the FTD3#6-PGRN
and the H9-hESC progeny (Figure 4A).
RNA-seq data corroborated our observation that cortical
neuronal differentiation from FTD-iPSCs is inefficient, as
here too, TUBB3, CTIP2, FOXG1, BLBP, and MAP2 were
significantly downregulated in FTD3#6, compared to H9-
hESC progeny, and restored in FTD3#6-PGRNprogeny (Fig-
ure 4B). Although we did not see an increase in apoptotic
cells, the RNA-seq data demonstrated that, in line with
the findings in the Almeida et al. (2012) paper, some com-20 Stem Cell Reports j Vol. 4 j 16–24 j January 13, 2015 j ª2015 The Authorponents of the MAPK pathway were differentially ex-
pressed in the d40 progeny of FTD3#6 cells compared
with FTD3#6-PGRN and H9-hESC progeny (Figure S4A).
Gene ontology analysis using DAVID demonstrated
that ‘‘neurogenesis,’’ ‘‘generation of neurons,’’ ‘‘neuron
development,’’ ‘‘neuron projection development,’’ and
‘‘synaptic transmission’’ were within the top ‘‘Biological
Processes’’ categories significantly enriched in FTD3#6
versus H9-hESC progeny and in FTD3#6-PGRN versus
FTD3#6 progeny. Ingenuity pathway analysis identified
Wnt/b-catenin signaling as one of the top altered path-
ways. Among other genes, WNT2, WNT3a, WNT5a,s
Figure 4. Genome-wide Transcriptome Analysis of d40 Neuronal Progeny
(A) Table with the significantly differentially expressed genes (using Benjamini-Hochberg-corrected p values).
(B) Represents the log fold change of gene transcripts of TUBB3, TBR1, FOXP2, CTIP2, FOXG1, BLBP, and MAP2 in d40 neural progeny of the
FTD3#6, H9-hESC, and FTD3#6-PGRN lines from RNA-seq studies.
(C) Wnt signaling pathway, overlaid with the differentially expressed genes (log2 ratio >1 or <1) of FTD3#6 versus H9-hESC line
comparison. Upregulated genes are in green, and downregulated genes are in red.
(D) Western blot for active and total b-catenin on H9-hESCs at d24 treated with DMSO or DMSO-IWP2 (IWP2). b-actin, internal control.
(E) Panel I: Relative expression of BLBP and FOXG1 transcripts in FTD3#6 treated with or without DMSO and IWP2 (n = 3 independent
experiments). Error bars indicate mean ± SEM; *p < 0.05, t test. Panel II: BLBP and FOXG1 transcripts in FTD3#6-iPSC treated with DMSO or
DMSO-IWP2 (IWP2). n = 3 independent experiments. Error bars indicate mean ± SEM. *p < 0.05, t test.
(F) Immunostaining on FTD3#6 d40 progeny treated with DMSO-IWP2 (IWP2) for NESTIN and BLBP or TUJ1 and CTIP2 (n = 3). Scale
bars, 100 mm.
See also Figure S4.
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expressed in FTD3#6 compared to FTD3#6-PGRN and H9-
hESCprogeny, whileGSK3b,APC, and PP2Awere expressed
significantly less in FTD3#6-iPSC progeny. However,
expression of genes from the WNT signaling pathway was
similar in FTD3#6-PGRN compared with H9-hESC neural
progeny (Figures 4C and S4B).
To address whether aberrantly activated WNT signaling
was, at least in part, responsible for the defective cortico-Stemgenesis, we induced cortical neuron differentiation of
FTD3#6, FTD3#6-PGRN, and H9-ESC lines in the presence
or absence of the WNT inhibitor, IWP2. Western blot anal-
ysis demonstrated that IWP2 inhibited active b-catenin
levels (Figure 4D). On d40 of differentiation, transcript
levels for BLBP and FOXG1 were significantly higher in
FTD3#6 progeny treated with IWP2, dissolved in DMSO,
compared to FTD3#6 treated with DMSO and untreated
cells (Figures 4E–4I). Of note, addition of DMSO aloneCell Reports j Vol. 4 j 16–24 j January 13, 2015 j ª2015 The Authors 21
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progeny, while IWP2 induced a further significant increase
in these transcripts. The increased frequency of neurons in
DMSO-treated FTD-iPSC progeny is possibly an indirect
effect of DMSO-induced PGRN upregulation, as previously
reported (Ong et al., 2006). Consistent with this notion,
addition of DMSO (and IWP2) to differentiation of
FTD3#6-PGRN (Figure 4EII) or H9-hESC (data not shown)
lines did not affect expression of cortical neuron markers.
Immunostaining demonstrated that more BLBP- and
CTIP2-positive cells were generated when IWP2 was added
during the cortical neuron differentiation of FTD3#6 cells
(Figure 4F). Again, this improvement was also visible in
the DMSO-treated cells (data not shown).DISCUSSION
We demonstrate that iPSCs generated from FTD patients
carrying aGRN IVS1+5G > C null mutation poorly differen-
tiate to cortical neurons, while differentiation to motor
neurons appears normal. Introduction of the GRN cDNA
in the AAVS1 locus of FTD-iPSCs using ZFN-mediated ho-
mologous recombination corrected the inefficient cortical
neuron generation. Loss of PGRN caused aberrant activa-
tion of theWNTsignaling pathway during neuronal differ-
entiation, and inhibition of WNT signaling partially
rescued the FTD-iPSC corticogenesis defect, further sub-
stantiating the notion that the WNT signaling pathway
might be a therapeutic target for FTD (Korade and Mirnics,
2011).
Almeida et al. (2012) previously demonstrated that
GRNS116X-iPSCs could be differentiated toward neurons
with a similar efficiency as that of control iPSCs but that
GRNS116X-iPSCs were more sensitive to stress. We chose to
differentiate neuronal progenitors from iPSC lines specif-
ically toward the cortical lineage, as we hypothesized that
evaluation of the influence of PGRN haploinsufficiency
on cortical neurons, the most affected cell type in FTD,
would likely yield the most important insights into the
disease. We induced cortical neuron differentiation and
demonstrated that generation of TUJ1-positive cells coex-
pressing cortical markers such as CTIP2, FOXP2, and
TBR1was significantly decreased in FTD-iPSCs. By contrast,
Almeida et al., who differentiated iPSCs sequentially as
embryoid bodies and neurospheres with additional growth
factors to generate a mixture of glutamatergic, GABAergic,
and dopaminergic neurons, did not observe decreased cell
differentiation. We hypothesize that the differences in the
efficiency of neural progeny generation between the two
studies might be caused by the specific subtype of neuronal
cells we generated. In fact, generation of HB9/TUJ1- and
ISLET-1/SMI32-positive motor neurons appeared similar22 Stem Cell Reports j Vol. 4 j 16–24 j January 13, 2015 j ª2015 The Authorwhen FTD-iPSC or H9-hESC lines were differentiated to
motor neurons.
The role of PGRN in cortical neurons is currently not well
understood. PGRN exerts neurotrophic properties through
a yet-unidentified receptor (De Muynck et al., 2013; Gass
et al., 2012; Van Damme et al., 2008). However, a strong
link between PGRN and the WNT signaling pathway in
neuronal physiology has been established. Rosen et al.
(2011), demonstrated thatGRN knockdown in primary hu-
man neurons activated the canonical and noncanonical
WNT signaling pathway. They also found similar WNT
signaling activation in transcriptome studies of human
GRN mutant brain. Furthermore, knockdown of GRN in a
neural progenitor cell line was shown to inhibit the level
of phosphorylated GSK3b, resulting in canonical WNT
signaling activation and hampered retinoic-acid-mediated
neural differentiation in human cells (Gao et al., 2010).
WNT signaling is also important for pre- and postnatal
neuronal development. WNTsignaling inhibits neuroecto-
derm and forebrain specification (Ming and Song, 2011).
Postnatally, WNT regulates proliferation and maturation
of neural progenitors in the hippocampus and dentate
gyrus (Miranda et al., 2012; Wexler et al., 2009). These
studies identify a very important role of WNT signaling
during brain development, as well as neurogenesis and
neural maturation postnatally.
Transcriptome studies on cortical neuron progeny from
FTD-iPSCs and isogenic genetically corrected FTD-iPSC
and CTRL lines revealed that WNT signaling was among
the top canonical signaling pathways deregulated by GRN
haploinsufficiency. This may explain the decrease in
mature cortical neurons generated, as WNT signaling was
shown to affect proliferation and maturation of cortical
neuronal progenitors (Wexler et al., 2009). However, we
could not identify aberrant activation of the WNT
signaling pathway in the Almeida et al. (2012) transcrip-
tome studies (Figure S4C), which may, again, be due to
differences in neurons generated.
We also demonstrated that aberrant WNT signaling is, at
least partly, responsible for the defective in vitro cortico-
genesis, based on differentiations wherein we added the
WNT inhibitor IWP2, which inhibits WNT processing
and secretion. WNT signaling abnormalities, observed in
our study, are also seen in brains of 6-week-old Grn/
mice (Rosen et al., 2011) before the occurrence of neuroin-
flammation or neuronal apoptosis, suggesting that
aberrant WNT signaling may be an early event in FTD
development. Future studies to assess whether sponta-
neous apoptosis occurs in FTD-iPSC neurons maintained
for longer periods of time, and whether this can be linked
to aberrant WNT signaling, will be of interest.
We found that in vitro corticogenesis is decreased in
GRNIVS1+5G > C-iPSCs; however, brain development ins
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PGRN Deficiency Induces Impaired CorticogenesisGrn+/ and Grn/ mice and in PGRN haploinsufficient pa-
tients appears normal. The reason for the discrepancies
in vitro and in vivo might be that excess of WNT signaling
during early steps of development can be compensated by
other morphogens or cellular interactions, not present in
the culture system. However, it is interesting that in pa-
tients with FTD, evidence of presymptomatic changes ex-
ists (Li et al., 2007).
Neurodegenerative diseases were thought to not be
readily recreated in vitro, as they are late-onset diseases.
However, several papers have shown that disease pheno-
types recapitulated to some extent, using iPSCs (Qiang
et al., 2013). This suggests that cellular and molecular
causes of these diseases of aging may often already be pre-
sent earlier during life and that additional events ulti-
mately lead to the full manifestation of the symptoms of
the disease. In addition, published studies, as well as the
study presented here, suggest that signaling events
required for neurodevelopment may also play major roles
in neurodegeneration and that targeting such pathways—
as for instance, the WNT pathway presented in this
study—may result in the creation of novel therapeutic
approaches for FTD.EXPERIMENTAL PROCEDURES
Primary human fibroblast cultures were obtained from skin bi-
opsies of FTD patients after informed consent; control iPSCs
were generated from BJ fibroblasts. Human iPSC lines were gener-
ated and characterized as previously described (Takahashi et al.,
2007b). hESC and iPSC lines were differentiated toward cortical
or motor neuron progeny as previously described (Espuny-Cama-
cho et al., 2013; Hu and Zhang, 2009). Gene targeting was per-
formed by use of ZFN technology in the AAVS1 locus of iPSCs.
For further information, see the Supplemental Experimental
Procedures.
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